Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Sell
3,297
-403
-11% -$45.8K 0.33% 113
2025
Q4
$393K Hold
3,700
0.37% 110
2025
Q3
$347K Hold
3,700
0.26% 158
2025
Q2
$321K Hold
3,700
0.19% 207
2025
Q1
$285K Buy
+3,700
New +$339K 0.2% 219

Other funds holding ACA

Corient IA's ACA Position: Q1 2026 in Review

Corient IA reduced its Arcosa (ACA) stake by 11% in Q1 2026, selling an estimated $45.8K and leaving 3,297 shares worth $350K. The position accounts for 0.33% of the portfolio, ranked #113.

Corient IA first reported a position in ACA in Q1 2025 and has held it in 5 quarters since. The position peaked at $393K in Q4 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Corient IA held 3,297 shares of Arcosa worth $350K as of Q1 2026.
  • Corient IA sold 403 Arcosa shares in Q1 2026, an estimated $45.8K.
  • Arcosa made up 0.33% of Corient IA's portfolio in Q1 2026, its #113 holding.
  • Corient IA first reported a position in Arcosa in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Arcosa position peaked at $393K in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.